Second, we performed several experiments using bioinformatic analysis, loss/gain-of-function, coimmunoprecipitation, and rescue experiments in vitro and revealed a novel role of NE transporter (NET) in NE-promoted colon cancer that underlies the antagonistic effect of VEN. Here, SLC6A2 is linked to malignant colon neoplasm.